A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
about
Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac DiseaseMicroRNAs in the Stressed Heart: Sorting the Signal from the NoiseMicroRNAs as therapeutic targets and biomarkers of cardiovascular diseaseGenetics and disease of ventricular muscle.Heart failure: advanced development in genetics and epigeneticsAn emerging role for the miR-26 family in cardiovascular disease.MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndromeA heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundancemiR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo.Deep sequencing of cardiac microRNA-mRNA interactomes in clinical and experimental cardiomyopathy.Ginsenoside-Rb1 Protects Hypoxic- and Ischemic-Damaged Cardiomyocytes by Regulating Expression of miRNAs.Decoding the cardiac message: the 2011 Thomas W. Smith Memorial Lecture.A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment.The role of microRNAs in cardiac development and regenerative capacity.Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 BiogenesisRegulation of cardiac microRNAs by cardiac microRNAs.A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis.Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.Mitochondrial dynamics in heart disease.microRNAs in cardiac development and regeneration.The role of microRNAs in cardiovascular disease.Epitranscriptional regulation of cardiovascular development and disease.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.Mitochondrial dynamics, mitophagy and cardiovascular disease.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.Genetic polymorphisms associated with heart failure: A literature review.Divergent Effects of miR-181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets.Myocardial recovery with mechanical circulatory support.MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNA.MicroRNAs and the butterfly effect.Pediatric Dilated Cardiomyopathy-Associated LRRC10 (Leucine-Rich Repeat-Containing 10) Variant Reveals LRRC10 as an Auxiliary Subunit of Cardiac L-Type Ca2+ Channels.A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease.A polymorphism rs3746444 within the pre-miR-499 alters the maturation of miR-499-5p and its antiapoptotic function
P2860
Q26801907-8F560B43-E26C-4A63-B7F5-5A9C7CFDC140Q26995334-D007CC5E-CA63-4E50-80A2-BD3AED754C4DQ27012405-2CDF2E0D-C714-4A39-9D84-FF97F8E7413EQ27691994-C9348EF5-F1D2-414D-98D0-E5306CF81254Q28080771-CE4992FB-3469-4AA8-A5E9-F3299896BB53Q34115775-E8C4D68A-F365-4EED-A6B8-610981713F40Q34336568-DD23048F-AABE-439A-A10F-63029C9CF2F0Q34623253-3EB5FEDA-67FE-489A-BC49-2BA123FBD18EQ35165504-1D9437C1-AA54-417D-9CE6-9CD91E24EB60Q35593966-37472540-E0E1-49FE-B2D4-4A32531AFCB2Q35667958-47F06DA9-9AD6-4640-8B09-C02B90852A13Q35804603-190ABB5D-A87E-4BD2-9B81-CF1864EDFB85Q36054858-CA42F7BB-D532-41F4-9CFE-ECAB79FE057BQ36194321-E06A14A9-C590-4083-ADE1-CCCC06EB9EFDQ36378208-97CE72BA-A4A7-404A-956A-4F675CD22881Q36497180-C56090A6-1DAB-4CF0-B604-20477DA8737DQ36699569-4B163ACB-5AB9-4EE2-891C-7672BE0ED692Q36917391-33113389-EB08-4A49-9A4D-E3C75D36BF74Q37162692-C7FE9B9A-F715-4E8D-9BEF-561A185F4A59Q37168474-7505039A-9E50-4070-BC3E-68BCF3C90226Q37234922-A13BDC0C-6C6D-4167-A625-6F9602DC4DF8Q37685243-0E2D53A6-4907-43C9-9142-8A09D953E4C2Q37997232-1816C8F4-D393-4800-AE5F-5F683D31A1D4Q38103312-1A50F7DB-D60A-442F-B8D8-04947C9A1AD3Q38189405-DC938EDC-6FAB-4B91-9B1A-91D953011DACQ38272573-7C42C8D5-EBB6-4F00-B07A-3808211B1E49Q38591803-F8CCCEA2-54A6-44B4-915B-A166F77B9326Q38625440-8B5F944E-C71D-45CF-893F-195F98CFC950Q38664137-E7FA1247-135B-498E-9241-4EFF1F458975Q38669417-F136A409-4F36-4EFA-BF48-CB1D80B8B75FQ38697467-B6C75233-EBA8-4474-97CF-A3FCEB94FC5DQ38714584-7547C924-4A89-4396-92CA-B13F5D80A97EQ38864091-E74B09B9-F4A4-44C9-A642-C9E6FCEBB7F1Q39248707-D26FD0F6-9BF0-4CA7-9518-54301917671DQ40689258-968A677D-D0F1-46FB-90C2-C1BB8C962992Q42873479-CF10EE75-366A-4291-A31F-E09562C55BFDQ42946967-B37A1517-8583-40EE-B4E0-32846C72EC0BQ50069576-FE71D8B2-2EAA-4022-A874-E70B376BDA4EQ51315251-1C41753A-E435-4DD4-824E-F089C9029955Q58783783-4D368100-F396-438D-A64C-05904DFA11F8
P2860
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@ast
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@en
type
label
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@ast
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@en
prefLabel
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@ast
A human 3' miR-499 mutation alters cardiac mRNA targeting and function.
@en
P2093
P2860
P1433
P1476
A human 3' miR-499 mutation alters cardiac mRNA targeting and function
@en
P2093
Gerald W Dorn
William H Eschenbacher
P2860
P304
P356
10.1161/CIRCRESAHA.111.260752
P577
2012-02-28T00:00:00Z